Brown, N., May, J. A., Wilcox, R. G., Allan, L. M., Wilson, A. M., Kiff, P. S., & Heptinstall, S. (1999). Comparison of antiplatelet activity of microencapsulated aspirin 162.5 mg (Caspac XL), with enteric coated aspirin 75 mg and 150 mg in patients with atherosclerosis. Blackwell Science Inc.
Citação norma ChicagoBrown, Nigel, Jane A. May, Robert G. Wilcox, Linda M. Allan, Adrian M. Wilson, Peter S. Kiff, and Stan Heptinstall. Comparison of Antiplatelet Activity of Microencapsulated Aspirin 162.5 Mg (Caspac XL), With Enteric Coated Aspirin 75 Mg and 150 Mg in Patients With Atherosclerosis. Blackwell Science Inc, 1999.
Citação norma MLABrown, Nigel, et al. Comparison of Antiplatelet Activity of Microencapsulated Aspirin 162.5 Mg (Caspac XL), With Enteric Coated Aspirin 75 Mg and 150 Mg in Patients With Atherosclerosis. Blackwell Science Inc, 1999.